News resources
| Incyte Corp (INCY) | 2 stories... |
| American International Group Inc (AIG) | 2 stories... |
| LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC) | 2 stories... |
| New York Times Co (NYT) | 1 story... |
| Ford Motor Co (F) | 1 story... |
| advertisement |
Bristol-Myers Squibb Co: All Recent News
- Final Glance: Pharmaceuticals companies 11/24/2009
- NEW YORK (AP) - Shares of some top pharmaceuticals companies were mixed at the close of trading:... Associated Press
- 4 Platform Drugmakers to Invest In 11/24/2009
- No special shoes required. At Motley Fool
- Early Glance: Pharmaceuticals companies 11/24/2009
- NEW YORK (AP) - Shares of some top pharmaceuticals companies are mixed at 10 a.m.:... Associated Press
- Bristol-Myers, Origin Lead High-Flying Stocks 11/24/2009
- Origin Agritech, Rockwell Collins, Xcel Energy, Accenture and Bristol-Myers Squibb hit 52-week highs. At TheStreet.com
- Zacks Analyst Blog Highlights: Pozen, Sanofi-Aventis,... 11/23/2009
- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Business Wire
- ($) Remember, Remember the Strength of November 11/23/2009
- Being this up going into year-end puts pressure on funds to avoid selling. At TheStreet.com
- Healthcare Stocks: Safe and Speculative 11/23/2009
- NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio. At TheStreet.com
- Bristol-Myers extends partnership with Asterand 11/23/2009
- NEW YORK (AP) - Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday. Associated Press
- Rocket Stocks for the Week 11/23/2009
- These stocks could surge higher in the coming week. At TheStreet.com
- ($) Sanofi Has Lots of Upside Catalysts 11/23/2009
- Looks like the patent worries aren't so dire after all. At TheStreet.com
- $ Review 11/21/2009
- ... At Barron's
- FDA OKs Abilify for autism-linked irritability 11/20/2009
- PRINCETON, N.J. (AP) - The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday. Associated Press
- U.S. Food and Drug Administration Approves ABILIFY®... 11/20/2009
- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA)... Business Wire
- Exxon Mobil, Bristol-Myers Squibb: Money Flow Leaders (XOM, BMY) 11/20/2009
- ... At Wall Street Journal
- $ Bristol-Myers Faces Lower Sales 11/20/2009
- ... At Barron's
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.

